(Q38088832)

28 August 2017

Kinase activation in circulating cells: opportunities for biomarkers for diagnosis and therapeutic monitoring (English)

1 reference

28 August 2017

0 references

Laurie L Parker

1

0 references

Stephen J. Kron

object named as

Stephen J Kron

series ordinal

2

0 references

language of work or name

English

0 references

publication date

1 January 2008

1 reference

Expert Opinion on Medical Diagnostics

28 August 2017

1 reference

28 August 2017

2

1 reference

28 August 2017

1

1 reference

28 August 2017

33-46

1 reference

The chronic myelogenous leukemia-specific P210 protein is the product of the bcr/abl hybrid gene

28 August 2017

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.1.33

The molecular biology of CML: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.1.33

Letter: A new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.1.33

Current and emerging treatment options in chronic myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.1.33

Circulating tumor cells: the 'leukemic phase' of solid cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.1.33

The effect of various cell separation procedures on assays of neutrophil function. A critical appraisal

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.1.33

Application of magnetic beads in bioassays.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.1.33

Alterations in cell signaling in sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.1.33

Src protein tyrosine kinase family and acute inflammatory responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.1.33

Resistance to endotoxic shock and reduced neutrophil migration in mice deficient for the Src-family kinases Hck and Fgr

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.1.33

Tyrosine protein kinase activity in normal and leukaemic human blood cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.1.33

Tyrosine kinase fusion genes in chronic myeloproliferative diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.1.33

After chronic myelogenous leukemia: tyrosine kinase inhibitors in other hematologic malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.1.33

A TEL-JAK2 fusion protein with constitutive kinase activity in human leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.1.33

Molecular genetic analysis of haematological malignancies: I. Acute leukaemias and myeloproliferative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.1.33

A road map for those who don't know JAK-STAT

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.1.33

Lymphoblastic leukemia/lymphoma in mice overexpressing the Mer (MerTK) receptor tyrosine kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.1.33

The hepatocyte growth factor/Met pathway controls proliferation and apoptosis in multiple myeloma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.1.33

Map kinase signaling pathways and hematologic malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.1.33

Extracellular signal-regulated kinase and p38 mitogen-activated protein kinase pathways cooperate in mediating cytokine-induced proliferation of a leukemic cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.1.33

The p38 MAPK pathway mediates the growth inhibitory effects of interferon-alpha in BCR-ABL-expressing cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.1.33

The Abl family kinases: mechanisms of regulation and signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.1.33

Emerging roles of pseudokinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.1.33

Regulation of the Jak2 tyrosine kinase by its pseudokinase domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.1.33

The pseudokinase domain is required for suppression of basal activity of Jak2 and Jak3 tyrosine kinases and for cytokine-inducible activation of signal transduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.1.33

Involvement of Jak2 tyrosine phosphorylation in Bcr-Abl transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.1.33

ABL-kinase domain point mutation as a cause of imatinib (STI571) resistance in CML patient who progress to myeloid blast crisis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.1.33

Detection of BCR-ABL mutations in patients with CML treated with imatinib is virtually always accompanied by clinical resistance, and mutations in the ATP phosphate-binding loop (P-loop) are associated with a poor prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.1.33

Real-time quantitative PCR analysis can be used as a primary screen to identify patients with CML treated with imatinib who have BCR-ABL kinase domain mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.1.33

Assaying Bcr-Abl kinase activity and inhibition in whole cell extracts by phosphorylation of substrates immobilized on agarose beads

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.1.33

Tracking cell signaling protein expression and phosphorylation by innovative proteomic solutions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.1.33

Technology insight: pharmacoproteomics for cancer--promises of patient-tailored medicine using protein microarrays

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.1.33

Development of a microsphere-based p38alpha MAP kinase no-wash assay.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.1.33

Analyzing protein kinase dynamics in living cells with FRET reporters.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.1.33

Mapping normal and cancer cell signalling networks: towards single-cell proteomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.1.33

Phosphoproteomics strategies for the functional analysis of signal transduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.1.33

Quantitative detection of phosphoproteins by combination of two-dimensional difference gel electrophoresis and phosphospecific fluorescent staining

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.1.33

A fluorescence polarization assay for native protein substrates of kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.1.33

Microarray platforms for enzymatic and cell-based assays

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.1.33

Protein microarray technology

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.1.33

Functional peptide microarrays for specific and sensitive antibody diagnostics

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.1.33

Global analysis of protein phosphorylation in yeast

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.1.33

Fully automated synthesis of (phospho)peptide arrays in microtiter plate wells provides efficient access to protein tyrosine kinase characterization

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.1.33

A rapid method for determining protein kinase phosphorylation specificity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.1.33

Protein-acrylamide copolymer hydrogels for array-based detection of tyrosine kinase activity from cell lysates

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.1.33

Kinase-catalyzed biotinylation for phosphoprotein detection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.1.33

Optimizing thiophosphorylation in the presence of competing phosphorylation with MALDI-TOF-MS detection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.1.33

Bio-orthogonal affinity purification of direct kinase substrates

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.1.33

Kinetics of B cell receptor signaling in human B cell subsets mapped by phosphospecific flow cytometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.1.33

Transcending the biomarker mindset: deciphering disease mechanisms at the single cell level

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.1.33

Proteinchip(R) surface enhanced laser desorption/ionization (SELDI) mass spectrometry: a novel protein biochip technology for detection of prostate cancer biomarkers in complex protein mixtures

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.1.33

Rapid screening of protein profiles of human breast cancer cell lines using non-porous reversed-phase high performance liquid chromatography separation with matrix-assisted laser desorption/ionization time-of-flight mass spectral analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.1.33

Global analysis of protein expression in yeast

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.1.33

Enrichment analysis of phosphorylated proteins as a tool for probing the phosphoproteome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.1.33

Characterization of protein phosphorylation by mass spectrometry using immobilized metal ion affinity chromatography with on-resin beta-elimination and Michael addition

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.1.33

Selective analysis of phosphopeptides within a protein mixture by chemical modification, reversible biotinylation and mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.1.33

Improved beta-elimination-based affinity purification strategy for enrichment of phosphopeptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.1.33

Quantitative chemical proteomics reveals mechanisms of action of clinical ABL kinase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.1.33

Photocleavable peptide hydrogel arrays for MALDI-TOF analysis of kinase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.1.33

Amino acid-coded tagging approaches in quantitative proteomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.1.33

Mass spectrometry-based peptide quantification: applications and limitations

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.1.33

Trypsin catalyzed 16O-to-18O exchange for comparative proteomics: tandem mass spectrometry comparison using MALDI-TOF, ESI-QTOF, and ESI-ion trap mass spectrometers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.1.33

Phosphoproteome and Kinome Analysis: Unique Perspectives on the Same Problem

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2.1.33

21 January 2018

Identifiers

DOI

10.1517/17530059.2.1.33

1 reference

28 August 2017

1 reference

PubMed ID

23485115